MedHexagon
- Financial, legal, consulting
MedHexagon is an advisory firm whose objective is to help biotech companies in achieving value-maximizing cross-border deal transactions by offering corporate and business development transaction support services including fundraising and BD support.
MedHexagon is founded by professionals each with 10+ years of well-rooted expertise in biotech and professional service industry, spanning across fundraising advisory, innovative drug cross-border transaction, management consulting, and an expansive network in the Chinese biotech space with global footprint (U.S., Europe, LATAM) through our partners.
We currently represent several early and late stage innovative drug assets seeking global out-licensing or M&A opportunities, as well as funds and local pharma seeking in-licensing and acquisition opportunities. Please connect with us to learn more.